Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Integra Lifesciences ( (IART) ) has shared an update.
Integra LifeSciences announced the appointment of Mojdeh Poul as its new President and CEO, effective January 2025. Poul, a seasoned executive with extensive experience in global healthcare businesses, succeeds Jan De Witte. She will focus on maximizing Integra’s product portfolio and executing strategic priorities. Her leadership is expected to drive innovation and operational excellence, setting new standards in surgical and regenerative care.
Find detailed analytics on IART stock on TipRanks’ Stock Analysis page.
